BRPI0822026A2 - Prepação farmacêutica ou nutracêutica revestida com liberação acentuada de substância ativa no cólon. - Google Patents

Prepação farmacêutica ou nutracêutica revestida com liberação acentuada de substância ativa no cólon.

Info

Publication number
BRPI0822026A2
BRPI0822026A2 BRPI0822026-3A2A BRPI0822026A BRPI0822026A2 BR PI0822026 A2 BRPI0822026 A2 BR PI0822026A2 BR PI0822026 A BRPI0822026 A BR PI0822026A BR PI0822026 A2 BRPI0822026 A2 BR PI0822026A2
Authority
BR
Brazil
Prior art keywords
nutracetic
colon
pharmaceutical
active substance
preparation coated
Prior art date
Application number
BRPI0822026-3A2A
Other languages
English (en)
Inventor
Hema Ravishankar
Shraddha Bodinge
Hans-Ulrich Petereit
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of BRPI0822026A2 publication Critical patent/BRPI0822026A2/pt
Publication of BRPI0822026B1 publication Critical patent/BRPI0822026B1/pt
Publication of BRPI0822026B8 publication Critical patent/BRPI0822026B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/30Encapsulation of particles, e.g. foodstuff additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72Encapsulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
BRPI0822026A 2008-01-10 2008-02-01 preparação farmacêutica ou nutracêutica, comprimido, gelatina ou cápsula de hpmc, e uso de uma ou uma mistura de uma pluralidade de polímeros ou copolímeros BRPI0822026B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN95CH2008 2008-01-10
IN95/CHE/2008 2008-01-10
PCT/EP2008/051236 WO2009086940A1 (en) 2008-01-10 2008-02-01 Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon

Publications (3)

Publication Number Publication Date
BRPI0822026A2 true BRPI0822026A2 (pt) 2014-10-07
BRPI0822026B1 BRPI0822026B1 (pt) 2019-05-07
BRPI0822026B8 BRPI0822026B8 (pt) 2021-05-25

Family

ID=39798120

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0822026A BRPI0822026B8 (pt) 2008-01-10 2008-02-01 preparação farmacêutica ou nutracêutica, comprimido, gelatina ou cápsula de hpmc, e uso de uma ou uma mistura de uma pluralidade de polímeros ou copolímeros

Country Status (14)

Country Link
US (1) US9237760B2 (pt)
EP (1) EP2230932B1 (pt)
JP (1) JP5409651B2 (pt)
KR (1) KR101500792B1 (pt)
CN (1) CN101877971A (pt)
BR (1) BRPI0822026B8 (pt)
CA (1) CA2711473C (pt)
ES (1) ES2626078T3 (pt)
HU (1) HUE034848T2 (pt)
IL (1) IL205488A (pt)
MX (1) MX2010007577A (pt)
PL (1) PL2230932T3 (pt)
SI (1) SI2230932T1 (pt)
WO (1) WO2009086940A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101443943B1 (ko) 2007-05-07 2014-10-07 에보니크 룀 게엠베하 가속된 약물 방출을 갖는 장용 코팅을 포함하는 고체 투여 형태
WO2013144176A1 (en) * 2012-03-30 2013-10-03 Laboratorios Del Dr. Esteve, S.A. Controlled release formulatin comprising mesalamine
US20140141075A1 (en) 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
US11229600B2 (en) * 2014-09-24 2022-01-25 Vital Beverages Global Inc. Compositions and methods for selective GI tract delivery
AU2015346037A1 (en) 2014-11-14 2017-07-06 Gemphire Therapeutics Inc. Processes and intermediates for preparing alpha,omega-dicarboxylic acid-terminated dialkane ethers
HUE052340T2 (hu) 2015-06-05 2021-05-28 Evonik Operations Gmbh Gyógyszer- vagy tápkészítmény etanol hatása elleni ellenállóképességgel
EP3344274A4 (en) 2015-09-01 2019-05-22 First Wave Bio, Inc. METHOD AND COMPOSITIONS FOR TREATING DISEASES RELATED TO ABNORMAL INFLAMMATORY REACTIONS
US10588864B2 (en) 2016-03-11 2020-03-17 Gateway Pharmaceuticals LLC Pharmaceutical compositions for colon-specific delivery
WO2017173068A1 (en) * 2016-03-30 2017-10-05 University Of Maryland, Baltimore Microparticulate system for colonic drug delivery
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
AR111786A1 (es) * 2017-05-11 2019-08-21 Gemphire Therapeutics Inc Composiciones de gemcabeno y su uso
JP7336187B2 (ja) * 2017-11-30 2023-08-31 日本ケミファ株式会社 多層構造を有する粒子状医薬組成物
CN114786652A (zh) 2019-12-11 2022-07-22 赢创运营有限公司 用于治疗或预防疾病的剂型
WO2021142238A1 (en) 2020-01-10 2021-07-15 First Wave Bio, Inc. Deuterated niclosamide
US20230190684A1 (en) 2020-03-16 2023-06-22 First Wave Bio, Inc. Methods of treating covid-19 with a niclosamide compound
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64726B1 (en) * 1987-11-20 1995-08-23 Elan Corp Plc Pharmaceutical formulations for preventing drug tolerance
FR2759293B1 (fr) 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
DE19845358A1 (de) * 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
DE10013029A1 (de) 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
DE10149674A1 (de) 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
DE10250543A1 (de) 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
MXPA04010956A (es) * 2003-01-30 2005-01-25 Roehm Gmbh Forma de dosis farmaceutica y metodo para la produccion de la misma.
DE10353196A1 (de) * 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix
DE10353186A1 (de) 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz
GB0403098D0 (en) 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
CN101484147B (zh) 2006-08-18 2015-07-08 赢创罗姆有限责任公司 对于具有水中良好溶解性的活性成分具有受控的活性成分释放性的药物组合物
DE102007009243A1 (de) 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit einer Wirkstoff-Matrix und einem Polymerüberzug, sowie ein Verfahren zur Herstellung der Pellets
KR101443943B1 (ko) 2007-05-07 2014-10-07 에보니크 룀 게엠베하 가속된 약물 방출을 갖는 장용 코팅을 포함하는 고체 투여 형태

Also Published As

Publication number Publication date
PL2230932T3 (pl) 2017-09-29
JP5409651B2 (ja) 2014-02-05
BRPI0822026B8 (pt) 2021-05-25
JP2011509264A (ja) 2011-03-24
EP2230932B1 (en) 2017-03-29
HUE034848T2 (en) 2018-03-28
SI2230932T1 (sl) 2017-07-31
CA2711473C (en) 2016-01-26
ES2626078T3 (es) 2017-07-21
US9237760B2 (en) 2016-01-19
KR20100103566A (ko) 2010-09-27
IL205488A (en) 2016-08-31
KR101500792B1 (ko) 2015-03-09
WO2009086940A1 (en) 2009-07-16
CA2711473A1 (en) 2009-07-16
US20100247639A1 (en) 2010-09-30
BRPI0822026B1 (pt) 2019-05-07
IL205488A0 (en) 2010-12-30
MX2010007577A (es) 2010-08-04
CN101877971A (zh) 2010-11-03
EP2230932A1 (en) 2010-09-29

Similar Documents

Publication Publication Date Title
BRPI0822026A2 (pt) Prepação farmacêutica ou nutracêutica revestida com liberação acentuada de substância ativa no cólon.
BRPI0814851A2 (pt) Combinações de substâncias ativas com propriedades inseticidsa e acaricidas
BRPI0821474A2 (pt) formulação farmacêutica líquida estável
BRPI0917315A2 (pt) anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
BRPI0908596A2 (pt) formulação e composição farmacêutica de liberação prolongada
BRPI0922450A2 (pt) sistema de formação de imagem com parte descartável.
BRPI0820819A2 (pt) Formulação de anticorpos
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0811232A2 (pt) Sistema de medição de componente respiratório.
BRPI0917358A2 (pt) formulação farmacêutica de liberação controlada e método.
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
BRPI0918641A2 (pt) Produtos infantis pró-bióticos.
DE602008000685D1 (de) Wässrige Copolymerlösung und Beschichtungszusammensetzung
DK2282994T3 (da) 3-aminocarbazolforbindelse, farmaceutisk sammensætning indeholdende forbindelsen samt fremstillingsmetode derfor
BRPI0817310A2 (pt) Ensaio de monitoramento de fármaco
BRPI0909416A2 (pt) Utensílios médicos com revestimentos hidrofílicos
BRPI0817974A2 (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas.
BRPI0921654A2 (pt) formulação farmacêutica
BRPI0908231A2 (pt) Sistema de liberação de fármaco com efeito estabilizante
BRPI0922341A2 (pt) composição farmacêutica revestida em fusão com liberação rápida.
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
BRPI0908959A2 (pt) aparelhos médicos com revestimentos hidrófilos
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23P 10/30 (2016.01), A23L 27/00 (2016.01), A61K 9

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/05/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/05/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/02/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25D Requested change of name of applicant approved

Owner name: ROEHM GMBH (DE)

B25G Requested change of headquarter approved

Owner name: ROEHM GMBH (DE)

B25A Requested transfer of rights approved

Owner name: EVONIK DEGUSSA GMBH (DE)

B25D Requested change of name of applicant approved

Owner name: EVONIK OPERATIONS GMBH (DE)